{"status": "ok", "totalResults": 72, "articles": [{"source": {"id": null, "name": "Moneycontrol"}, "author": "Hindi.Moneycontrol.com Team, Moneycontrol Hindi", "title": "Covid-19 \u0915\u0947 \u092c\u093e\u0930\u0947 \u092e\u0947\u0902 \u092c\u091a\u094d\u091a\u094b\u0902 \u0915\u094b \u0915\u0948\u0938\u0947 \u092c\u0924\u093e\u090f\u0902, \u090f\u0915\u094d\u0938\u092a\u0930\u094d\u091f \u0928\u0947 \u0926\u0940 \u092f\u0939 \u0938\u0932\u093e\u0939", "description": "\u0915\u094b\u0930\u094b\u0928\u093e \u0935\u093e\u092f\u0930\u0938 \u092e\u0939\u093e\u092e\u093e\u0930\u0940 \u0926\u0941\u0928\u093f\u092f\u093e \u092d\u0930 \u0915\u0947 \u0915\u0908 \u0926\u0947\u0936\u094b\u0902 \u0915\u094b \u0905\u092a\u0928\u0940 \u091a\u092a\u0947\u091f \u092e\u0947\u0902 \u0932\u0947 \u091a\u0941\u0915\u0940 \u0939\u0948\u0964 \u092f\u0939 \u090f\u0915 \u0910\u0938\u0940 \u092e\u0939\u093e\u092e\u093e\u0930\u0940 \u0939\u0948 \u091c\u094b \u0916\u0924\u094d\u092e \u0939\u094b\u0928\u0947 \u0915\u093e \u0928\u093e\u092e \u0928\u0939\u0940\u0902 \u0932\u0947 \u0930\u0939\u0940 \u0939\u0948\u0964 \u090f\u0915 \u0932\u0939\u0930, \u0926\u0942\u0938\u0930\u0940 \u0932\u0939\u0930, \u0924\u0940\u0938\u0930\u0940 \u0932\u0939\u0930.... \u0928 \u091c\u093e\u0928\u0947 \u0915\u093f\u0924\u0928\u0940 \u0932\u0939\u0930 \u0906\u090f\u0902\u0917\u0940, \u0907\u0938\u0915\u093e \u092d\u0940 \u0915\u094b\u0908 \u0905\u0902\u0926\u093e\u091c\u093e \u0928\u0939\u0940\u0902 \u0939\u0948\u0964 \u0907\u0938 \u092e\u0939\u093e\u092e\u093e\u0930\u0940 \u0928\u0947 \u092c\u091a\u094d\u091a\u094b\u0902 \u0924\u0915 \u0915\u094b \u0928\u0939\u0940\u0902 \u091b\u094b\u0921\u093c\u093e \u0939\u0948\u0964 \u0910\u0938\u0947\u2026", "url": "http://hindi.moneycontrol.com/news/india/trends/omicron-recombinant-how-to-tell-children-about-covid-19-know-expert-advice-584881.html", "urlToImage": "https://images.moneycontrol.com/static-hindinews/2022/05/KidsCoronaAFB-758x435.jpg", "publishedAt": "2022-05-22T02:52:06Z", "content": ", , .... , , , - (psychiatrist) , , 6-7 - - -"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Rachita Prasad", "title": "Explained: Centre cuts excise duty on petrol, diesel. Could prices come down more or will they rise again?", "description": "With the excise duty cut alone, the effective retail price of petrol will be reduced by around Rs 9.5 per litre and of diesel by Rs 7 per litre.", "url": "https://www.moneycontrol.com/news/business/economy/explained-centre-cuts-excise-duty-on-petrol-diesel-could-prices-come-down-more-or-will-they-rise-again-8551411.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2018/09/Fuel-price-Petrol-Diesel-770x433.jpg", "publishedAt": "2022-05-21T15:55:34Z", "content": "The central government on May 21 announced a reduction in the excise duty levied on petrol and diesel to give relief to consumers reeling under the pressure of high fuel prices.\r\nFinance Minister Nir\u2026 [+5336 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Container Corporation of India; target of Rs 680: ICICI Direct", "description": "ICICI Direct is bullish on Container Corporation of India has recommended buy rating on the stock with a target price of Rs 680 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-container-corporation-of-india-target-of-rs-680-icici-direct-8549771.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-21T15:19:31Z", "content": "ICICI Direct's research report on Container Corporation of India\r\nConcor is the dominant player in the CTO business (65% market share) with ~60 terminals. Revenue from rail transportation comprised 7\u2026 [+860 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Bosch; target of Rs 16,100: ICICI Direct", "description": "ICICI Direct is bullish on Bosch has recommended buy rating on the stock with a target price of Rs 16,100 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-bosch-target-of-rs-16100-icici-direct-8549791.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2017/03/buySell4-770x433.jpg", "publishedAt": "2022-05-21T15:19:26Z", "content": "ICICI Direct's research report on Bosch\r\nBosch Ltd (Bosch) is a technology leader providing solutions in automotive, industrial technology, consumer goods, energy &amp; building technology. Mobility \u2026 [+1007 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Dr Reddy#39;s Laboratories; target of Rs 4800: ICICI Direct", "description": "ICICI Direct is bullish on Dr Reddy#39;s Laboratories has recommended buy rating on the stock with a target price of Rs 4800 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-dr-reddys-laboratories-target-of-rs-4800-icici-direct-8549821.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2017/03/Buy_1-770x433.jpg", "publishedAt": "2022-05-21T15:19:23Z", "content": "ICICI Direct's research report on Dr Reddy's Laboratories\r\nDr Reddys (DRL) portfolio includes pharmaceutical generics, APIs, custom pharmaceutical services, biosimilar and complex formulations. Reven\u2026 [+1019 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Indraprastha Gas; target of Rs 440: ICICI Direct", "description": "ICICI Direct is bullish on Indraprastha Gas has recommended buy rating on the stock with a target price of Rs 440 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-indraprastha-gas-target-of-rs-440-icici-direct-8549851.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2017/03/BUY_Sell1-770x433.jpg", "publishedAt": "2022-05-21T15:19:21Z", "content": "ICICI Direct's research report on Indraprastha Gas\r\nIndraprastha Gas (IGL) is one of Indias largest city gas distribution companies and primarily operates in NCT of Delhi. CNG sales contribute more t\u2026 [+675 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Somany Ceramics; target of Rs 780: ICICI Direct", "description": "ICICI Direct is bullish on Somany Ceramics has recommended buy rating on the stock with a target price of Rs 780 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-somany-ceramics-target-of-rs-780-icici-direct-8549841.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2017/03/Buy_1-770x433.jpg", "publishedAt": "2022-05-21T15:19:19Z", "content": "ICICI Direct's research report on Somany Ceramics\r\nSomany Ceramics (SCL) is the second largest tiles manufacturers in the domestic tiles market having ~63 MSM capacity (as of Q4) and sanitaryware, fa\u2026 [+944 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Hold JK Lakshmi Cement; target of Rs 580: ICICI Direct", "description": "ICICI Direct recommended hold rating on JK Lakshmi Cement with a target price of Rs 580 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/hold-jk-lakshmi-cement-target-of-rs-580-icici-direct-8549861.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/hold-3-770x433.jpg", "publishedAt": "2022-05-21T15:19:15Z", "content": "ICICI Direct's research report on JK Lakshmi Cement\r\nJK Lakshmi mainly caters to north, west &amp; eastern markets with total capacity of 13.3 MT (including subsidiary). It has integrated units at Si\u2026 [+975 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Hold Pidilite Industries; target of Rs 2000: ICICI Direct", "description": "ICICI Direct recommended hold rating on Pidilite Industries with a target price of Rs 2000 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/hold-pidilite-industries-target-of-rs-2000-icici-direct-8549941.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/hold-1-770x433.jpg", "publishedAt": "2022-05-21T15:19:13Z", "content": "ICICI Direct's research report on Pidilite Industries\r\nPidilite is a market leader in the adhesive and sealants business. The companys consumer &amp; bazaar (C&amp;B) segment (adhesives &amp; sealant\u2026 [+809 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Hold Lupin; target of Rs 610: ICICI Direct", "description": "ICICI Direct recommended hold rating on Lupin with a target price of Rs 610 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/hold-lupin-target-of-rs-610-icici-direct-8549951.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/hold-2-770x433.jpg", "publishedAt": "2022-05-21T15:19:11Z", "content": "ICICI Direct's research report on Lupin\r\nLupin is a multinational pharma company engaged in manufacturing &amp; marketing branded &amp; generic formulations, APIs, biotech products as well as OTC med\u2026 [+1152 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Hindi.Moneycontrol.com Team, Moneycontrol Hindi", "title": "LPG Subsidy: \u092a\u0947\u091f\u094d\u0930\u094b\u0932-\u0921\u0940\u091c\u0932 \u0915\u0947 \u092c\u093e\u0926 200 \u0930\u0941\u092a\u090f \u0938\u0938\u094d\u0924\u093e \u0939\u0941\u0906 \u0917\u0948\u0938 \u0938\u093f\u0932\u0947\u0902\u0921\u0930, \u0907\u0928 9 \u0915\u0930\u094b\u0921\u093c \u0932\u094b\u0917\u094b\u0902 \u0915\u094b \u092e\u093f\u0932\u0947\u0917\u093e \u092b\u093e\u092f\u0926\u093e", "description": "\u0915\u0947\u0902\u0926\u094d\u0930 \u0915\u0940 \u0928\u0930\u0947\u0902\u0926\u094d\u0930 \u092e\u094b\u0926\u0940 \u0938\u0930\u0915\u093e\u0930 \u0928\u0947 \u0936\u0928\u093f\u0935\u093e\u0930 \u0915\u094b \u092e\u0939\u0902\u0917\u093e\u0908 \u0915\u0940 \u092e\u093e\u0930 \u091d\u0947\u0932 \u0930\u0939\u0940 \u0906\u092e \u091c\u0928\u0924\u093e \u0915\u094b \u0921\u092c\u0932 \u0930\u093e\u0939\u0924 \u0926\u0940 \u0939\u0948\u0964 \u0915\u0947\u0902\u0926\u094d\u0930 \u0928\u0947 \u092a\u0947\u091f\u094d\u0930\u094b\u0932 \u0914\u0930 \u0921\u0940\u091c\u0932 \u092a\u0930 \u090f\u0915\u094d\u0938\u093e\u0907\u091c \u0921\u094d\u092f\u0942\u091f\u0940 \u0915\u092e \u0915\u0930\u0928\u0947 \u0915\u0947 \u0905\u0932\u093e\u0935\u093e \u0909\u091c\u094d\u091c\u0935\u0932\u093e \u092f\u094b\u091c\u0928\u093e \u0915\u0947 \u0932\u093e\u092d\u093e\u0930\u094d\u0925\u093f\u092f\u094b\u0902 \u0915\u094b 200 \u0930\u0941\u092a\u090f \u092a\u094d\u0930\u0924\u093f \u0917\u0948\u0938 \u0938\u093f\u0932\u0947\u0902\u0921\u0930 \u0915\u0940 \u0938\u092c\u094d\u0938\u093f\u0921\u0940 \u0926\u0947\u0928\u0947 \u0915\u093e \u092d\u0940 \u0910\u0932\u093e\u0928 \u0915\u093f\u092f\u093e \u0939\u0948\u0964 \u0915\u0947\u0902\u0926\u094d\u0930 \u0928\u0947 \u0936\u0928\u2026", "url": "http://hindi.moneycontrol.com/news/commodity/lpg/200-rupees-subsidy-on-lpg-prices-to-over-9-crore-under-ujjwala-yojana-scheme-says-nirmala-sitharaman-584841.html", "urlToImage": "https://images.moneycontrol.com/static-hindinews/2022/05/LPG01OctFB-770x430.jpg", "publishedAt": "2022-05-21T15:10:13Z", "content": "Also, this year, we will give a subsidy of Rs 200 per gas cylinder (upto 12 cylinders) to over 9 crore beneficiaries of Pradhan Mantri Ujjwala Yojana: Union Finance Minister Nirmala Sitharaman\r\n ANI \u2026 [+18 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Gland Pharma: target of Rs 3770: Sharekhan", "description": "Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 3770 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-gland-pharma-target-of-rs-3770-sharekhan-8549991.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-21T15:00:41Z", "content": "Sharekhan's research report on Gland Pharma\r\nGland reported healthy results for Q4FY22 with the revenues staging a strong double digit growth while PAT staged a 9.8% yoy growth. Gland has lined up a \u2026 [+948 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy NTPC: target of Rs 170: Sharekhan", "description": "Sharekhan is bullish on NTPC has recommended buy rating on the stock with a target price of Rs 170 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-ntpc-target-of-rs-170-sharekhan-2-8549981.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/01/Buy-770x433.png", "publishedAt": "2022-05-21T15:00:41Z", "content": "Sharekhan's research report on NTPC\r\nQ4FY22 adjusted PAT of Rs. 4,560 crore (up 19% y-o-y) was above our estimate led by fuel cost over-recovery of Rs. 238 crore, RoE contribution from project commer\u2026 [+1267 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Ashok Leyland: target of Rs 165: Sharekhan", "description": "Sharekhan is bullish on Ashok Leyland has recommended buy rating on the stock with a target price of Rs 165 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-ashok-leyland-target-of-rs-165-sharekhan-8550001.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-21T15:00:39Z", "content": "Sharekhan's research report on Ashok Leyland\r\nStrong performance in Q4FY22 with revenue, EBITDA and PAT were ahead of expectations by 5.2%, 28.9% and 56.7% respectively. ALL is expected to benefit fr\u2026 [+952 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Zydus Lifesciences: target of Rs 440: Sharekhan", "description": "Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 440 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-zydus-lifesciences-target-of-rs-440-sharekhan-8550011.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-05-21T15:00:36Z", "content": "Sharekhan's research report on Zydus Lifesciences\r\nZydus reported steady operating performance for Q4FY2022, adjusting for the inventory provisioning related to Covid products and results were ahead \u2026 [+952 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy V-Guard Industries: target of Rs 280: Sharekhan", "description": "Sharekhan is bullish on V-Guard Industries has recommended buy rating on the stock with a target price of Rs 280 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-v-guard-industries-target-of-rs-280-sharekhan-3-8550051.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-1-770x433.jpg", "publishedAt": "2022-05-21T15:00:33Z", "content": "Sharekhan's research report on V-Guard Industries\r\nV-Guard Industries Ltds (VGILs) standalone performance bettered estimates on all fronts, with strong growth in the Electricals (~33%) and Consumer D\u2026 [+1108 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Hindustan Petroleum Corporation: target of Rs 310: Sharekhan", "description": "Sharekhan is bullish on Hindustan Petroleum Corporation has recommended buy rating on the stock with a target price of Rs 310 in its research report dated May 20, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-hindustan-petroleum-corporation-target-of-rs-310-sharekhan-8550031.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/buy-2-1-770x433.jpg", "publishedAt": "2022-05-21T15:00:33Z", "content": "\"Indias specialty chemicals industry is a\u00a0decadal growth opportunity and it is still not too late to participate in the value\u00a0creation process. We prefer CRAMS/CSM players Navin Fluorine (Navin) and \u2026 [+1728 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Pidilite Industries: target of Rs 2550: Sharekhan", "description": "Sharekhan is bullish on Pidilite Industries has recommended buy rating on the stock with a target price of Rs 2550 in its research report dated May 19, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-pidilite-industries-target-of-rs-2550-sharekhan-8550071.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-21T15:00:30Z", "content": "Sharekhan's research report on Pidilite Industries\r\nPidilite Industries (Pidilite) Q4FY2022 numbers were below par with subdued sales volume and a sharp decline in OPM led by raw material inflation r\u2026 [+1213 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Godrej Consumer Products: target of Rs 959: Sharekhan", "description": "Sharekhan is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of Rs 959 in its research report dated May 19, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-godrej-consumer-products-target-of-rs-959-sharekhan-2-8550091.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-05-21T15:00:26Z", "content": "Sharekhan's research report on Godrej Consumer Products\r\nGodrej Consumer Products (GCPL) Q4FY2022 was affected by global commodity inflation, a slowdown in the domestic market and sustained subdued p\u2026 [+1216 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Dr. Reddy\u00e2\u0080\u0099s Laboratories: target of Rs 5550: Sharekhan", "description": "Sharekhan is bullish on Dr. Reddy\u00e2\u0080\u0099s Laboratories has recommended buy rating on the stock with a target price of Rs 5550 in its research report dated May 19, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-dr-reddys-laboratories-target-of-rs-5550-sharekhan-2-8550101.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/buy-2-1-770x433.jpg", "publishedAt": "2022-05-21T15:00:24Z", "content": "\"Indias specialty chemicals industry is a\u00a0decadal growth opportunity and it is still not too late to participate in the value\u00a0creation process. We prefer CRAMS/CSM players Navin Fluorine (Navin) and \u2026 [+1455 chars]"}]}